Finn Hatherell speaks with Niamh Donnelly the Chief Robotics Officer at Akara Robotics
Posted:
They discuss the difficulty in scaling a hardware focused tech company, why robotics could be the next major tech boom after AI and how it could potentially revolutionise the healthcare sector.
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers. …
Wearable technology that monitors our bodies can be helpful and harmful.
Wearable technology affords the opportunity to check, re-check, and check again, leading to fixation.
Read the full article in the Psychology Today blog post here.